| Dr Nichola Bott, DC | |
|
992 High Ridge Rd, 3rd Floor, Stamford, CT 06905-1616 | |
| (203) 321-0000 | |
| (203) 322-0300 |
| Full Name | Dr Nichola Bott |
|---|---|
| Gender | Female |
| Speciality | Chiropractic |
| Experience | 34 Years |
| Location | 992 High Ridge Rd, Stamford, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245356575 | NPI | - | NPPES |
| 050000873CT01 | Other | CT | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 000873 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nichola Bott, DC 992 High Ridge Rd, Third Floor, Stamford, CT 06905-1616 Ph: (203) 321-0000 | Dr Nichola Bott, DC 992 High Ridge Rd, 3rd Floor, Stamford, CT 06905-1616 Ph: (203) 321-0000 |
News Archive
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today announces that it has started a Phase II proof of concept study with CNV2197944 in pain associated with post-herpetic neuralgia.
Robots and prosthetic devices may soon have a sense of touch equivalent to, or better than, the human skin with the Asynchronous Coded Electronic Skin, an artificial nervous system developed by a team of researchers at the National University of Singapore.
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
› Verified 4 days ago
Strawberry Hill Chiropractic Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: One Strawberry Hill Court, Ste L4, Stamford, CT 06902 Phone: 203-325-2990 Fax: 203-353-9572 | |
Dr. Elissa Diamond, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1250 Summer St, Suite 202, Stamford, CT 06905 Phone: 203-327-3222 Fax: 203-978-9079 | |
Mr. Mel Gabriel, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 19 3rd St, Stamford, CT 06905 Phone: 203-325-1533 Fax: 203-327-9656 | |
David C Avallon, Chiropractor Medicare: Medicare Enrolled Practice Location: 1 Atlantic St Ste 201, Stamford, CT 06901 Phone: 203-355-2225 Fax: 203-355-2235 | |
Dr. Ian Wyatt Keyser, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 970 Summer St Fl 1, Stamford, CT 06905 Phone: 203-276-1293 | |
Dr. Michael Anthony Naccarella, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1867 Summer St, Stamford, CT 06905 Phone: 203-975-7000 Fax: 203-975-0876 | |
Stamford Healthcare Associates, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1425 Bedford St. Unit 1g, Stamford, CT 06905 Phone: 203-569-0067 Fax: 203-504-2951 |